Elisa results demonstrated a significant increase in both inflammatory markers and S100A12 expression in the serum of mice with acute sepsis; however, treatment with amlexanox was able to suppress the inflammatory response and reduce S100A12 expression (Figures 9B–E). This evidence concerns the gene S100A12 and Sepsis.